---
title: "Fludrocortisone Acetate - Addison Disease - 2"
sidebar: mydoc_sidebar
permalink: db00687-mesh-d000224-2.html
toc: false 
---


Path ID: `DB00687_MESH_D000224_2`
{% include image.html url="images/db00687-mesh-d000224-2.png" file="db00687-mesh-d000224-2.png" alt="db00687-mesh-d000224-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C034635">MESH:C034635 </a> | Fludrocortisone acetate | Drug |
| <a href="https://identifiers.org/MESH:D005438">MESH:D005438 </a> | Fludrocortisone | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P08235">UniProt:P08235 </a> | Mineralocorticoid receptor | Protein |
| <a href="https://identifiers.org/GO:0070294">GO:0070294 </a> | Renal sodium ion absorption | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D012964">MESH:D012964 </a> | Sodium | ChemicalSubstance |
| <a href="https://identifiers.org/HP:0002632">HP:0002632 </a> | Blood pressure | PhenotypicFeature |
| <a href="https://identifiers.org/GO:0070295">GO:0070295 </a> | Renal water absorption | BiologicalProcess |
| <a href="https://identifiers.org/GO:0036359">GO:0036359 </a> | Renal potassium excretion | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D011188">MESH:D011188 </a> | Potassium | ChemicalSubstance |
| <a href="https://identifiers.org/HP:0002153">HP:0002153 </a> | Hyperkalemia | PhenotypicFeature |
| <a href="https://identifiers.org/HP:0002615">HP:0002615 </a> | Hypotension | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D000224">MESH:D000224 </a> | Addison disease | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Fludrocortisone Acetate | HAS METABOLITE | Fludrocortisone |
| Fludrocortisone | INCREASES ACTIVITY OF | Mineralocorticoid Receptor |
| Mineralocorticoid Receptor | POSITIVELY CORRELATED WITH | Renal Sodium Ion Absorption |
| Renal Sodium Ion Absorption | INCREASES ABUNDANCE OF | Sodium |
| Sodium | NEGATIVELY CORRELATED WITH | Hypotension |
| Mineralocorticoid Receptor | POSITIVELY CORRELATED WITH | Renal Potassium Excretion |
| Renal Potassium Excretion | DECREASES ABUNDANCE OF | Potassium |
| Potassium | CONTRIBUTES TO | Hyperkalemia |
| Hyperkalemia | MANIFESTATION OF | Addison Disease |
| Mineralocorticoid Receptor | POSITIVELY CORRELATED WITH | Renal Water Absorption |
| Renal Water Absorption | POSITIVELY CORRELATED WITH | Blood Pressure |
| Blood Pressure | NEGATIVELY CORRELATED WITH | Hypotension |
| Hypotension | MANIFESTATION OF | Addison Disease |
|---------|-----------|---------|

Comment: Fludrocortisone acetate is a prodrug of fludrocortisone, a synthetic mineralocorticoid used in conjunction with hydrocortisone

Reference: 
  - [https://go.drugbank.com/drugs/DB00687](https://go.drugbank.com/drugs/DB00687)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Fludrocortisone#section=Pharmacology](https://pubchem.ncbi.nlm.nih.gov/compound/Fludrocortisone#section=Pharmacology)
